Ginsenoside Rb1 Targets the HRD1-STING Axis to Mitigate Cholesterol-Induced VSMC Senescence. [PDF]
Niu H +5 more
europepmc +1 more source
Ginsenoside Rb1 Ameliorates Age-Related Cognitive Impairment Potentially by Modulating the NF-κB Signaling Pathway. [PDF]
Lu WF +4 more
europepmc +1 more source
Ginsenoside Rb1 alleviates overtraining-induced oxidative stress in mouse liver by stimulating mitophagy via Nrf2 pathway. [PDF]
Lu J, Xu R, Gao Y, Zong L, Wang D, Li J.
europepmc +1 more source
Gut microbiome and metabolome in aneurysm rat with hypertension after ginsenoside Rb1 treatment. [PDF]
Zeng Z +5 more
europepmc +1 more source
Ginsenoside Rb1 targets the NRF2-PPARγ-ACSL4 axis to inhibit PTECs ferroptosis. [PDF]
Tan B +10 more
europepmc +1 more source
Ginsenoside Rb1 alleviates endothelial dysfunction and vascular remodeling in preeclampsia via activation of the PI3K-Akt-eNOS pathway. [PDF]
Jia W, Wang W, Zhang B, Wang C, Huang X.
europepmc +1 more source
Ginsenoside Rb1 Mitigates Myocardial Fibrosis Through Inhibiting Exosomal-Derived miRNA-21-Associated Inflammation and Cardiac Signaling. [PDF]
Wang S +8 more
europepmc +1 more source
Ferulic acid in combination with ginsenoside Rb1 alleviates myocardial no-reflow by inhibiting platelet HMGB1 release and NET formation. [PDF]
Li J +9 more
europepmc +1 more source
Pharmacological activation of SIRT1-AMPK by ginsenoside Rb1: a novel therapeutic strategy for pressure injury <i>via</i> dual suppression of ferroptosis and inflammation. [PDF]
Zhu H +6 more
europepmc +1 more source
Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles. [PDF]
Du L, Lu H, Xiao Y, Guo Z, Li Y.
europepmc +1 more source

